Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: A0A3S7WP03
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 22 | 24 | PF00675 | 0.379 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.635 |
CLV_PCSK_FUR_1 | 89 | 93 | PF00082 | 0.703 |
CLV_PCSK_KEX2_1 | 22 | 24 | PF00082 | 0.365 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.594 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.624 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.667 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 71 | 75 | PF00082 | 0.615 |
DOC_CYCLIN_RxL_1 | 67 | 77 | PF00134 | 0.415 |
DOC_USP7_MATH_1 | 90 | 94 | PF00917 | 0.470 |
DOC_WW_Pin1_4 | 53 | 58 | PF00397 | 0.531 |
LIG_14-3-3_CanoR_1 | 89 | 95 | PF00244 | 0.526 |
LIG_BRCT_BRCA1_1 | 29 | 33 | PF00533 | 0.480 |
LIG_FHA_1 | 53 | 59 | PF00498 | 0.513 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.427 |
LIG_FHA_2 | 8 | 14 | PF00498 | 0.594 |
LIG_LIR_Gen_1 | 61 | 72 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 30 | 36 | PF02991 | 0.449 |
LIG_LIR_Nem_3 | 61 | 67 | PF02991 | 0.436 |
LIG_SH2_CRK | 46 | 50 | PF00017 | 0.430 |
LIG_SH2_NCK_1 | 12 | 16 | PF00017 | 0.694 |
LIG_SH2_SRC | 12 | 15 | PF00017 | 0.603 |
LIG_SH2_STAP1 | 12 | 16 | PF00017 | 0.591 |
LIG_SH2_STAP1 | 46 | 50 | PF00017 | 0.433 |
LIG_SH2_STAT5 | 26 | 29 | PF00017 | 0.335 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.444 |
LIG_TRAF2_1 | 11 | 14 | PF00917 | 0.669 |
LIG_TRAF2_1 | 79 | 82 | PF00917 | 0.419 |
LIG_TYR_ITIM | 44 | 49 | PF00017 | 0.369 |
LIG_UBA3_1 | 32 | 39 | PF00899 | 0.327 |
LIG_WRPW_2 | 6 | 9 | PF00400 | 0.625 |
MOD_CK2_1 | 53 | 59 | PF00069 | 0.523 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.594 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.417 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.738 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.437 |
MOD_N-GLC_1 | 52 | 57 | PF02516 | 0.705 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.624 |
MOD_PIKK_1 | 77 | 83 | PF00454 | 0.450 |
MOD_PK_1 | 45 | 51 | PF00069 | 0.433 |
MOD_PKA_2 | 90 | 96 | PF00069 | 0.498 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.496 |
MOD_Plk_4 | 45 | 51 | PF00069 | 0.267 |
MOD_ProDKin_1 | 53 | 59 | PF00069 | 0.530 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.414 |
TRG_ENDOCYTIC_2 | 6 | 9 | PF00928 | 0.625 |
TRG_ENDOCYTIC_2 | 64 | 67 | PF00928 | 0.388 |
TRG_ER_diArg_1 | 70 | 72 | PF00400 | 0.420 |
TRG_ER_diArg_1 | 88 | 91 | PF00400 | 0.458 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBL3 | Leptomonas seymouri | 74% | 100% |
A0A1X0P0H9 | Trypanosomatidae | 57% | 69% |
A0A422NDL6 | Trypanosoma rangeli | 47% | 91% |
A4H469 | Leishmania braziliensis | 89% | 100% |
A4HSE4 | Leishmania infantum | 100% | 100% |
D0A4K0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9AKD0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4QJH8 | Leishmania major | 90% | 100% |
V5AVY7 | Trypanosoma cruzi | 54% | 100% |